These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 310413)

  • 1. Cellular differentiation markers in lymphoproliferative diseases.
    Siegal FP
    Hosp Pract; 1978 Oct; 13(10):79-89. PubMed ID: 310413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surface markers of lymphocytes in lymphoproliferative diseases].
    Burchardt K
    Pol Arch Med Wewn; 1976 Dec; 56(6):579-83. PubMed ID: 826893
    [No Abstract]   [Full Text] [Related]  

  • 3. Surface markers in leukemias and lymphomas.
    Siegal FP; Filippa DA; Koziner B
    Am J Pathol; 1978 Feb; 90(2):451-60. PubMed ID: 304673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface cell markers in human lymphoid malignancies.
    Seligmann M; Preud'homme JL; Brouet JC
    Recent Results Cancer Res; 1976; (56):91-7. PubMed ID: 1087446
    [No Abstract]   [Full Text] [Related]  

  • 5. The human T-cell leukemias: clinical, cytomorphologic, immunophenotypic, and genotypic characteristics.
    Knowles DM
    Hum Pathol; 1986 Jan; 17(1):14-33. PubMed ID: 3002948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Membrane markers in lymphoproliferative disorders.
    Lancet; 1975 Mar; 1(7908):670-1. PubMed ID: 47088
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology.
    Koziner B; Filippa DA; Mertelsmann R; Gupta S; Clarkson B; Good RA; Siegal FP
    Am J Med; 1977 Oct; 63(4):556-67. PubMed ID: 303053
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical patterns in B lymphoid malignancy.
    Galton DA; MacLennan IC
    Clin Haematol; 1982 Oct; 11(3):561-87. PubMed ID: 6756734
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic markers for classification of leukemias and non-Hodgkin lymphomas.
    Thierfelder S; Rodt H; Thiel E; Hoffmann-Fezer G; Netzel B; Haas RJ; Wündisch GF; Bender-Götze C
    Recent Results Cancer Res; 1979; 69():41-8. PubMed ID: 382307
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical manifestations of lymphoproliferative disorders of thymic origin].
    Pintado Cros T
    Sangre (Barc); 1984; 29(4-C):731-40. PubMed ID: 6240122
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
    Macintyre EA
    Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492
    [No Abstract]   [Full Text] [Related]  

  • 13. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface markers in hematologic malignancies.
    Freedman AS; Nadler LM
    Semin Oncol; 1987 Jun; 14(2):193-212. PubMed ID: 3296201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity and cellular origins of T cell malignancies.
    Greaves MF; Rao J; Hariri G; Verbi W; Catovsky D; Kung P; Goldstein G
    Leuk Res; 1981; 5(4-5):281-99. PubMed ID: 6974808
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of monoclonal antibodies in hematology].
    Pagnucco G; Bernasconi C
    Riv Emoter Immunoematol; 1984; 31(1):1-35. PubMed ID: 6085185
    [No Abstract]   [Full Text] [Related]  

  • 17. T lymphomas associated with human T-cell leukemia-lymphoma virus may show phenotypic and functional differences from adult T-cell leukemias.
    Yamada Y; Amagasaki T; Kamihira S; Kinoshita K; Ikeda S; Kusano M; Suzuyama J; Toriya K; Tomonaga Y; Ichimaru M
    Clin Immunol Immunopathol; 1985 Sep; 36(3):306-19. PubMed ID: 2990783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases.
    Knowles DM; Halper JP
    Am J Pathol; 1982 Feb; 106(2):187-203. PubMed ID: 6978074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma and leukemia of t-lymphocytes.
    Watanabe S; Shimosato Y; Shimoyama M
    Pathol Annu; 1981; 16(Pt 2):155-203. PubMed ID: 7036059
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood lymphoma-leukemia. I. Correlation of morphology and immunological studies.
    Williams AH; Taylor CR; Higgins GR; Quinn JJ; Schneider BK; Swansson V; Parker JW; Pattengale PK; Chandor SB; Powars D; Lincoln TL; Tindle BH; Lukes RJ
    Cancer; 1978 Jul; 42(1):171-81. PubMed ID: 352504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.